BCF Life Sciences
BCF Life Sciences, founded 1986 in France, extracts free L-Cystine, L-Tyrosine, carbocistein and keratin hydrolysates from poultry feathers via proprietary acid hydrolysis. It supplies these specialty ingredients to pharmaceutical, nutraceutical, infant nutrition, aquaculture, sustainable agriculture and pet food manufacturers globally.
- Company typePrivate
- Founded1986
- HeadquartersPleucadeuc, France
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What BCF Life Sciences does
BCF Life Sciences, founded in 1986 in Pleucadeuc, Morbihan (France), is a specialty biochemical manufacturer that extracts and valorizes free amino acids — principally L-Cystine, L-Tyrosine, carbocistein, and proprietary keratin hydrolysates — from poultry feather keratin via a proprietary 13-30 step acid hydrolysis process. The 15-hectare Food Grade production site, operating 24/7, is the only European facility synthesizing carbocistein from on-site L-Cystine, and the company is vertically integrated from raw feather intake to finished ingredient, supported by €6.1M (2024) reverse-osmosis water reuse infrastructure and ICPE / European Pharmacopoeia / GMP+ / Ecocert / ANSM / PMDA certifications.
The portfolio spans six market segments: human health (nutraceutical flagship Kera-Diet® for skin/hair/nails, pure L-Cystine and L-Tyrosine for supplements, carbocistein API for expectorants, and infant/medical nutrition including Phenylketonuria applications), aquaculture (Kera-Stim® 20/50/88 functional amino acid line for shrimp and fish feed, backed by 10+ university partnerships and 40+ monitored trials), sustainable agriculture (Ecocert-approved Leafamine® and Fertilamine® biostimulants with two patents granted in 2023 and 2025), and pet care (high-digestibility amino acid mixes for hypoallergenic veterinary diets).
The business model is B2B ingredient supply sold directly to manufacturers through a specialist sales force that pairs with in-house R&D. Revenue grew approximately 3x since 2009, with 64% of turnover from export and 88.5% of 2020 revenue tied to human, animal or plant health applications. The company is privately held, backed by MBO & CO and CEREA PARTNER with a deeply aligned employee ownership culture (80% of staff became shareholders via FCPE in 2019), and operates from headquarters in Pleucadeuc plus representative offices in Bangkok and Tokyo.
BCF Life Sciences firmographics
Firmographics- Name
- BCF Life Sciences
- Legal name
- BCF Life Sciences
- Website
- https://bcf-lifesciences.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- BCF Life Sciences, founded 1986 in France, extracts free L-Cystine, L-Tyrosine, carbocistein and keratin hydrolysates from poultry feathers via proprietary acid hydrolysis. It supplies these specialty ingredients to pharmaceutical, nutraceutical, infant nutrition, aquaculture, sustainable agriculture and pet food manufacturers globally.
- Ownership category
- akta.pro rank
BCF Life Sciences industry classification
Industry- Product category
- Specialty Amino Acid Ingredients
- NAICS
- Animal Food Manufacturing (3111), Food Manufacturing (311)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
- akta.pro primary industry
- Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ)
- akta.pro secondary industries
- Amino Acid Premixes & Concentrates (AFADAGAE), Manufacturing, Private Label & Co-Manufacturing for Animal Diets (HLAMAHAO), Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins) (AFAJAHAL)
Keywords
Where BCF Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Pleucadeuc
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
BCF Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Amino Acid Product Sales: BCF Life Sciences sells pure and mixed free amino acids (L-Cystine, L-Tyrosine, carbocistein) and specialty formulations (Kera-Diet®, Kera-Stim®, Leafamine®, Cysti-White®) to manufacturers in human health, aquaculture, agriculture, and pet care markets. Company states 'We only sell what we produce' indicating vertical integration from raw material to finished product.
- Human Health Ingredients: Products for nutraceutical (dietary supplements), infant and medical nutrition, and pharmaceutical applications. 88.5% of 2020 turnover contributed to applications improving human health or animal/plant nutrition and health.
- Aquaculture Feed Additives: Kera-Stim® functional amino acid products for shrimp and fish feed. Supported by partnership network with 10+ universities and research centers, 40 monitored shrimp trials, 18 fish trials, 5 scientific publications.
- Agricultural Biostimulants: Leafamine® and Fertilamine products for sustainable agriculture, approved by Ecocert for organic farming. Unique mix of 17 free amino acids for plant nutrition and stress resistance.
- Pet Care Ingredients: Amino acid mixes up to 88% content and 82% free amino acids for pet food formulations, particularly for vet diets addressing food allergies.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
BCF Life Sciences product offering
Product offeringCore offering
BCF Life Sciences manufactures and sells free amino acids (L-Cystine, L-Tyrosine) and their derivatives (Carbocistein, Kera-Diet®, Kera-Stim®, Leafamine®, Fertilamine®, Cysti-White®) extracted from poultry feather keratin using a proprietary acid hydrolysis process. The products are sold B2B to manufacturers in pharmaceutical, nutraceutical, infant nutrition, aquaculture, sustainable agriculture, and pet food industries from a 15-hectare production site in Pleucadeuc, France.
Product overview
BCF Life Sciences operates as a manufacturer of free amino acids extracted from poultry feather keratin through a unique industrial process. The product portfolio centers on Kera-Diet® (flagship nutraceutical keratin hydrolysate for skin, hair, and nails) and pure amino acids (L-Cystine, L-Tyrosine) for supplements and pharmaceuticals. The aquaculture line features Kera-Stim® range products for shrimp and fish nutrition. For agriculture, the company offers Fertilamine and Leafamine® biostimulants. Pet care products include free amino acid mixes for pet food formulations. The company also produces Carbocistein for pharmaceuticals and Cysti-White® for skin lightening.
Differentiator
Problem solved
Functional benefit
Brands
- Kera-Diet®: Flagship product - keratin hydrolysate for skin, hair and nails nutraceutical applications with proven clinical performance
- Cysti-White®
- Kera-Stim®
- Kera-Aqua
- Fertilamine
- Leafamine
- PlantCare
- Kera-Diet
Products and services
- Kera-Diet® Extensively hydrolyzed keratin hydrolysate derived from poultry feathers for skin, hair and nails care. Contains 17 amino acids with over 94% in free form, molecular weight 100% < 800 Daltons, and 96.2% average digestibility. Supported by randomized double-blind placebo-controlled clinical studies.
- Cysti-White® Oral dietary supplement combining Traced L-Cystine with Glutathione, supplemented with antioxidants, amino acids, trace elements and vitamins, designed for safe skin lightening effect.
- L-Cystine Pure amino acid extracted from keratin, available in multiple granulum sizes (850 µm, 250 µm screened, 180 µm micronized). Used in food supplements for hair and nails growth and vitality, infant nutrition, and pharmaceutical formulations. Compliant with European Pharmacopoeia.
- L-Tyrosine Amino acid precursor of dopamine, beneficial for cognitive functions (memory and stress management). Also precursor of melanin for skin pigmentation. Available in Low Phenylalanine quality for Phenylketonuria patients.
- Carbocistein Pharmaceutical active ingredient synthesized from L-Cystine produced on the Pleucadeuc site. Used in expectorant syrup formulas. BCF Life Sciences is the only European company synthesizing Carbocistein from L-Cystine produced on its site.
- Kera-Stim® Range Functional amino acids product line for aquaculture (shrimp and fish). Contains unique mix of 17 free amino acids with 81% in free form and 12 functional amino acids. Three concentration levels available: Kera-Stim 20 (liquid, 20% AA), Kera-Stim 50 (powder, 50% AA), Kera-Stim 88 (88% AA).
- Fertilamine Plant biostimulant product containing 17 natural free amino acids for sustainable agriculture. Approved by Ecocert for use in Organic Agriculture. Applied via roots for protein synthesis and biostimulant effects.
- Leafamine® Plant biostimulant technology with patented applications for leaf absorption and soil regeneration. Part of PlantCare by BCF Life Sciences. Contains unique mix of 17 natural free amino acids.
- Free Amino Acid Mixes (Pet Care) Hydrolyzed amino acid mixes for pet food applications. Up to 88% amino acid content, up to 82% free amino acids, 100% < 800 Da molecular weight. Designed for vet diets to avoid food allergies in cats and dogs.
Quantifiable outcome
- 96.2% average amino acid digestibility for Kera-Diet® (range 84.4-99.2%)
- +5 more outcomes
Companies that use BCF Life Sciences
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles6 records
BCF Life Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
BCF Life Sciences partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor, core and historical.
- GTMminorCivil engineering contractor (2 people) for construction of the water treatment plant infrastructure.
- OvivecoreWater treatment specialist that built and jointly operates BCF Life Sciences' 6.1M EUR wastewater treatment and reuse plant using reverse osmosis technology. Partnership enables 80,000 m3 annual water savings and supports 50% capacity increase.
- CCI France JapancoreFrench Chamber of Commerce and Industry in Japan hosting BCF Life Sciences' North Asia representative office in Tokyo, supporting 25+ years of presence in Japanese market.
- 10+ Universities and Research CenterscorePartnership network supporting aquaculture R&D with more than 10 universities and research centers across Europe, Southeast Asia, and Latin America. Supports 40+ monitored shrimp trials and 18 monitored fish trials.
- Guyomarc'h GrouphistoricalOriginal parent company; poultry industry group that decided to utilize co-products (feathers) from its slaughterhouses, leading to creation of Bretagne Chimie Fine (BCF Life Sciences) in 1986. Feather keratin is the raw material source for amino acid extraction.
Scale indicators12 records
Recent moves10 records
Expansion highlights5 records
BCF Life Sciences competitors and assessment
Company assessmentRegional players
- Symrise (Diana Pet Food): Symrise's Diana Pet Food division is a global leader in pet food palatability and nutrition ingredients. Notably, Diana Group (later Symrise) was BCF's corporate parent from 2005, providing direct historical familiarity with BCF's capabilities. Today both companies serve pet food formulators with protein hydrolysates and functional ingredients for hypoallergenic diets.
Direct peers
- Novus International: Novus International is a specialty animal nutrition company producing amino acids (methionine hydroxy analog HMTBa), organic trace minerals, and enzymes for feed applications. Its focus on functional feed additives for aquaculture, poultry, and swine mirrors BCF's Kera-Stim® aquaculture line and aquaculture R&D partnership network.
- Gelita: Gelita is a global leader in collagen peptide manufacturing, producing hydrolyzed proteins from animal byproducts (bones, hides) for nutraceutical, food, and pet food applications. The technology base (protein hydrolysis to defined molecular weight profiles) and end-market mix closely mirror BCF's keratin hydrolysate business, particularly in nutricosmetics and pet nutrition.
- Tessenderlo Group (PB Leiner): Through its PB Leiner subsidiary, Tessenderlo Group produces gelatin and collagen hydrolysates from animal-derived protein sources using proprietary hydrolysis processes — directly comparable to BCF's keratin acid hydrolysis technology and hydrolysate product range (Kera-Diet, Kera-Stim). Both serve nutraceutical, food, and animal nutrition markets with branded protein-based functional ingredients.
- Kemin Industries: Kemin Industries is a specialty ingredient manufacturer focused on animal nutrition, pet food, and human health, producing protein hydrolysates, antioxidants, and functional ingredients. Its pet food and aquaculture ingredient portfolios overlap with BCF's Kera-Stim® and pet care amino acid mix products, particularly in palatability and digestibility applications.
Broad incumbents
- CJ CheilJedang: CJ CheilJedang produces amino acids (lysine, tryptophan, methionine, valine) and nucleotides via fermentation for animal feed, food, and cosmetics. As a major Korean fermentation-based amino acid supplier, it competes with BCF in functional amino acid blends for feed and human nutrition, particularly in Asian markets where BCF has a long-standing presence.
- Croda International: Croda is a global specialty ingredients company serving personal care, health, and crop care markets with bioactive functional ingredients. Through its Life Sciences and Consumer Care divisions, it competes with BCF in premium nutraceutical and nutricosmetics actives, with comparable go-to-market via clinical/technical validation and B2B ingredient brands.
- Evonik Industries: Evonik is one of the world's largest producers of amino acids (MetAMINO, Biolys, ThreAMINO) primarily via fermentation for animal feed. While using a different production technology at vastly greater scale, Evonik competes with BCF in the specialty amino acid space, particularly for aquaculture and livestock feed applications where functional amino acids are increasingly specified.
- Yara International: Yara is the world's largest crop nutrition company, producing fertilizers and increasingly biostimulants for sustainable agriculture. Its crop solutions division competes with BCF's Leafamine® and Fertilamine products in the plant biostimulant space, where amino acid-based formulations for foliar and root application are gaining adoption.
- Ajinomoto: Ajinomoto is the global leader in amino acid production via fermentation, with deep presence in pharmaceutical-grade amino acids, nutraceuticals (including L-Cystine and L-Tyrosine), and food ingredients. It is the dominant low-cost alternative to BCF's acid hydrolysis route and serves overlapping end-markets including infant nutrition and supplements.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
BCF Life Sciences social profiles
Digital presenceBCF Life Sciences compliance and trust
Trust signalCompliance10 records
BCF Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
BCF Life Sciences leadership team
Management profileNumber of profiles
Profiles6 records
BCF Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BCF Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BCF Life Sciences
What does BCF Life Sciences do?
BCF Life Sciences manufactures and sells free amino acids (L-Cystine, L-Tyrosine) and their derivatives (Carbocistein, Kera-Diet®, Kera-Stim®, Leafamine®, Fertilamine®, Cysti-White®) extracted from poultry feather keratin using a proprietary acid hydrolysis process. The products are sold B2B to manufacturers in pharmaceutical, nutraceutical, infant nutrition, aquaculture, sustainable agriculture, and pet food industries from a 15-hectare production site in Pleucadeuc, France.
Is BCF Life Sciences a public or private company?
BCF Life Sciences is a private company. It is classified as private equity controlled and is currently operating.
When was BCF Life Sciences founded?
BCF Life Sciences was founded in 1986. It employs 101 to 250 people.
Where is BCF Life Sciences based?
BCF Life Sciences is headquartered in Pleucadeuc, France, in the Europe region.
How does BCF Life Sciences make money?
Five revenue lines are on record. Amino Acid Product Sales are the primary driver. The others are human Health Ingredients, aquaculture Feed Additives, agricultural Biostimulants and pet Care Ingredients.
Who are BCF Life Sciences's main competitors?
Symrise (Diana Pet Food) is listed as a regional player. Direct peers are Novus International, Gelita, Tessenderlo Group (PB Leiner) and Kemin Industries. Broad incumbents are CJ CheilJedang, Croda International, Evonik Industries, Yara International and Ajinomoto.
Does BCF Life Sciences have an API?
No public API is recorded for BCF Life Sciences.
What industry is BCF Life Sciences in?
BCF Life Sciences's product category is Specialty Amino Acid Ingredients. Its primary akta.pro industry code is CRADAOAJ, Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids), with a secondary code of AFADAGAE, Amino Acid Premixes & Concentrates. Its NAICS code is 3111 and its SIC code is 2833.